Iron Overload After Hematopoietic Stem Cell Transplantation (HSCT) in Patients With Beta-thalassemia Major
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Post Hematopoietic Stem Cell Transplantation (NCT01610297) | Novartis Pharmaceuticals | 2013-09-01 |
Track Iron Overload After Hematopoietic Stem Cell Transplantation (HSCT) in Patients With Beta-thalassemia Major automatically
Every clearance here is in the API, with alerts when new ones post.